Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America
- 1 March 2001
- journal article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 7 (3), 152-157
- https://doi.org/10.1046/j.1198-743x.2001.00230.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Antimicrobial Resistance withStreptococcus pneumoniaein the United States, 1997–98Emerging Infectious Diseases, 1999
- Comparison of Activities of Broad-Spectrum β-Lactam Compounds against 1,128 Gram-Positive Cocci Recently Isolated in Cancer Treatment CentersAntimicrobial Agents and Chemotherapy, 1999
- The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsisCancer, 1996
- Bacteremia due to viridans streptococci in neutropenic patients: A reviewAmerican Journal Of Medicine, 1994
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- The Changing Epidemiology of Infections at Cancer HospitalsClinical Infectious Diseases, 1993
- Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing FactorsClinical Infectious Diseases, 1992
- Bacterial Endocarditis at a Small Community HospitalThe American Journal of the Medical Sciences, 1990
- Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with CancerNew England Journal of Medicine, 1988
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966